Evidence map›Paper›PMID 34976561›Full record

ArticleIEEE access : practical innovations, open solutions2020

Classification of COVID-19 and Other Pathogenic Sequences: A Dinucleotide Frequency and Machine Learning Approach.

Gciniwe S Dlamini, Stephanie J Muller, Rebone L Meraba, Richard A Young, James Mashiyane, Tapiwa Chiwewe, Darlington S Mapiye

Abstract read
In one paragraph

Article in IEEE access : practical innovations, open solutions, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. First-line drug resistance profiling ofAMIA ... Annual Symposium proceedings. AMIA Symposium · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gciniwe S DlaminiIBM Research Johannesburg 2001 South Africa.ORCID https://orcid.org/0000-0002-8926-5595
Stephanie J MullerIBM Research Johannesburg 2001 South Africa.ORCID https://orcid.org/0000-0003-3997-4446
Rebone L MerabaIBM Research Johannesburg 2001 South Africa.ORCID https://orcid.org/0000-0002-9744-1405
Richard A YoungIBM Research Johannesburg 2001 South Africa.ORCID https://orcid.org/0000-0002-0240-8224
James MashiyaneIBM Research Johannesburg 2001 South Africa.ORCID https://orcid.org/0000-0001-6602-8936
Tapiwa ChiweweIBM Research Johannesburg 2001 South Africa.ORCID https://orcid.org/0000-0002-7381-908X
Darlington S MapiyeIBM Research Johannesburg 2001 South Africa.ORCID https://orcid.org/0000-0001-8403-8783

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The world is grappling with the COVID-19 pandemic caused by the 2019 novel SARS-CoV-2. To better understand this novel virus and its relationship with other pathogens, new methods for analyzing the genome are required. In this study, intrinsic dinucleotide genomic signatures were analyzed for whole genome sequence data of eight pathogenic species, including SARS-CoV-2. The genome sequences were transformed into dinucleotide relative frequencies and classified using the extreme gradient boosting (XGBoost) model. The classification models were trained to a) distinguish between the sequences of all eight species and b) distinguish between sequences of SARS-CoV-2 that originate from different geographic regions. Our method attained 100% in all performance metrics and for all tasks in the eight-species classification problem. Moreover, the models achieved 67% balanced accuracy for the task of classifying the SARS-CoV-2 sequences into the six continental regions and achieved 86% balanced accuracy for the task of classifying SARS-CoV-2 samples as either originating from Asia or not. Analysis of the dinucleotide genomic profiles of the eight species revealed a similarity between the SARS-CoV-2 and MERS-CoV viral sequences. Further analysis of SARS-CoV-2 viral sequences from the six continents revealed that samples from Oceania had the highest frequency of TT dinucleotides as well as the lowest CG frequency compared to the other continents. The dinucleotide signatures of AC, AG,CA, CT, GA, GT, TC, and TG were well conserved across most genomes, while the frequencies of other dinucleotide signatures varied considerably. Altogether, the results from this study demonstrate the utility of dinucleotide relative frequencies for discriminating and identifying similar species.

Indexed as

Alignment-free sequence analysisCOVID-19dinucleotide frequenciesfeature representationsgenomic signatureshuman pathogensmachine learningXGBoost

Identifiers

PMID34976561
PMCPMC8675546

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.